Latest Marketable Securities News

Page 1 of 7
Region Group has extended its on-market securities buy-back program by 12 months, aiming to optimise its portfolio while maintaining capital for growth opportunities.
Claire Turing
Claire Turing
24 Mar 2026
Novo Resources Corp. reported a net loss of CAD 22.4 million for 2025, slightly improving from the previous year, while securing a $5.9 million capital raise to support ongoing exploration and operations.
Maxwell Dee
Maxwell Dee
23 Mar 2026
Imricor Medical Systems has filed a Form 10 registration with the U.S. SEC, marking its transition to a U.S. reporting company amid ongoing FDA clearances and clinical trials. This move signals a significant step in its early commercialisation of MRI-guided cardiac ablation technology.
Ada Torres
Ada Torres
19 Mar 2026
Dexus Convenience Retail REIT has extended its on-market securities buy-back program for another year, aiming to repurchase up to 2.5% of its securities to enhance shareholder value amid current trading conditions.
Eva Park
Eva Park
9 Mar 2026
Dexus Industria REIT has announced an on-market securities buy-back targeting 2.5% of its issued securities, aiming to enhance returns for investors. The buy-back is set to commence from 24 March 2026 following a mandatory waiting period.
Eva Park
Eva Park
9 Mar 2026
Dexus has announced a 19.3 cents per security distribution for HY26, aligned with its updated payout policy, alongside robust financial results and a strategic 10% on-market buyback to address valuation gaps.
Eva Park
Eva Park
27 Feb 2026
ReNerve Limited reported a half-year loss of $2.72 million, up 47% from last year, as it expands its nerve repair product portfolio and secures new regulatory approvals in Asia-Pacific.
Ada Torres
Ada Torres
26 Feb 2026
Imricor Medical Systems saw a sharp 69.5% decline in revenue for 2025, driven by clinical trial impacts, yet narrowed its net loss to $25.3 million as it secured FDA clearance for key products post-year-end.
Ada Torres
Ada Torres
25 Feb 2026
Genesis Energy has completed a NZ$100 million share placement at NZ$2.15 per share, paving the way for a NZ$300 million rights offer to fund its renewable energy expansion under the Gen35 strategy.
Maxwell Dee
Maxwell Dee
24 Feb 2026
Livium Ltd has turned a profit in the first half of FY26 despite lower revenues, supported by cost cuts and a new joint venture. The company also secured $4.5 million in fresh capital to expand its lithium-ion battery recycling and rare earth initiatives.
Maxwell Dee
Maxwell Dee
18 Feb 2026
Dexus has announced a new on-market buyback of up to 10% of its securities, aiming to address the disconnect between its market valuation and underlying asset values while maintaining capital discipline.
Eva Park
Eva Park
18 Feb 2026
SHAPE Australia Corporation Limited reported a robust half-year performance with a 48.5% rise in net profit and declared a fully franked 14 cent interim dividend, underpinned by strategic acquisition and operational discipline.
Victor Sage
Victor Sage
18 Feb 2026